ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,084,000 | -54.9% | 366,290 | -8.8% | 0.00% | -50.0% |
| Q4 2021 | $11,266,000 | -26.0% | 401,505 | -10.4% | 0.01% | -33.3% |
| Q3 2021 | $15,229,000 | -20.0% | 448,035 | -3.8% | 0.01% | -25.0% |
| Q2 2021 | $19,029,000 | +684.7% | 465,729 | +673.0% | 0.02% | +700.0% |
| Q1 2021 | $2,425,000 | -90.0% | 60,247 | -85.4% | 0.00% | -91.7% |
| Q4 2020 | $24,370,000 | +63.5% | 412,134 | +34.4% | 0.02% | +41.2% |
| Q3 2020 | $14,908,000 | +25.4% | 306,565 | +24.8% | 0.02% | +21.4% |
| Q2 2020 | $11,887,000 | +1904.6% | 245,705 | +1050.4% | 0.01% | +1300.0% |
| Q1 2020 | $593,000 | -42.4% | 21,358 | -37.9% | 0.00% | 0.0% |
| Q4 2019 | $1,029,000 | -46.6% | 34,397 | -45.0% | 0.00% | -50.0% |
| Q3 2019 | $1,927,000 | -80.4% | 62,571 | -69.3% | 0.00% | -77.8% |
| Q2 2019 | $9,844,000 | – | 203,805 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |